FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Lifts Greenwich Flamingo-01 Trial Hold

[ Price : $8.95]

FDA lifts its clinical hold on a Greenwich LifeSciences Phase 3 trial of the companys invasive breast cancer investigational treat...

Catalyst Says Jacobus Patent Suit is Settled

[ Price : $8.95]

Catalyst says it has settled its patent litigation with Jacobus over Catalysts Firdapse and Jacobus Ruzurgi.

Comments Extended on Drug Shortages Guide

[ Price : $8.95]

Federal Register notice: FDA extends the comment period on a draft guidance entitled Risk Management Plans to Mitigate the Potenti...

Elite Supplement Center Illegally Selling SARM Products: FDA

[ Price : $8.95]

FDA warns Elite Supplement Center that it is illegally marketing selective androgen receptor modulator products that are legally c...

Byondis BLA for Breast Cancer Therapy Accepted

[ Price : $8.95]

FDA accepts for review a Byondis BLA for SYD985 ([vic-] trastuzumab duocarmazine) for use in patients with HER2-positive unresecta...

FDA Authorizes Watmind At-Home Covid Antigen Test

[ Price : $8.95]

FDA grants an emergency use authorization to Watmind USA for its over-the-counter at-home Covid-19 antigen test.

Fresenius Propoven 2% Emulsion Authorization Revoked

[ Price : $8.95]

Federal Register notice: FDA revokes an Emergency Use Authorization issued to Fresenius Kabi USA for its Fresenius Propoven 2% Emu...

31 No-Longer-Marketed ANDAs Withdrawn

[ Price : $8.95]

Federal Register notice: FDA withdraws approval of 31 ANDAs from multiple applicants because the products are no longer marketed.

FDA Slow to Inspect Monkeypox Vaccine Facility: Article

[ Price : $8.95]

A New York Magazine investigative report says FDA is partly responsible for delays in getting sufficient monkeypox vaccine doses i...

Abbott Deep Brain Depression Device is Breakthrough Device

[ Price : $8.95]

FDA grants breakthrough device designation to the Abbott deep brain stimulation system for use in treatment-resistant depression.